Related Experiment Video
Updated: Jun 4, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[New challenges in community-acquired pneumonia]
Francisco Sanz Herrero1, Nuria Marina Malanda, Beatriz Montull Veiga
1Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia, España. sanz_fraher@gva.es
Archivos De Bronconeumologia
|February 15, 2011
Summary
Community-acquired pneumonia (CAP) poses significant health risks. Severity assessment tools and emerging biomarkers aid in risk stratification and treatment, improving patient outcomes.
Area of Science:
- * Pneumonia research spans clinical management, diagnostics, and therapeutic innovations.
- * Focuses on respiratory medicine and infectious diseases.
Context:
- * Community-acquired pneumonia (CAP) is a leading cause of illness and death globally.
- * Accurate severity assessment is crucial for guiding treatment intensity.
- * Established scales like PSI/Fine and CURB-65 are standard clinical tools.
Purpose:
- * To review current strategies for pneumonia severity assessment and etiological diagnosis.
- * To highlight advancements in virological diagnostics and treatment approaches.
- * To explore the potential of immunomodulatory drugs in managing pneumonia.
Summary:
- * CAP management relies on validated severity scales (PSI/Fine, CURB-65) and biomarkers.
- * Rapid polymerase chain reaction (PCR) enhances etiological diagnosis, particularly for viral pneumonia.
- * Bacterial superinfection is a key complication in viral pneumonias.
- * Novel therapeutic avenues, including immunomodulatory drugs, show promise.
Impact:
- * Improved patient stratification and tailored treatment intensity for CAP.
- * Enhanced diagnostic accuracy for pneumonia, especially viral causes.
- * Potential for new therapeutic strategies to modify pneumonia outcomes.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...